title: Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations.
authors.forename: Willem A
authors.initials: WA
authors.lastname: Hanekom
authors.forename: Hazel M
authors.initials: HM
authors.lastname: Dockrell
authors.forename: Tom H M
authors.initials: TH
authors.lastname: Ottenhoff
authors.forename: T Mark
authors.initials: TM
authors.lastname: Doherty
authors.forename: Helen
authors.initials: H
authors.lastname: Fletcher
authors.forename: Helen
authors.initials: H
authors.lastname: McShane
authors.forename: Frank F
authors.initials: FF
authors.lastname: Weichold
authors.forename: Dan F
authors.initials: DF
authors.lastname: Hoft
authors.forename: Shreemanta K
authors.initials: SK
authors.lastname: Parida
authors.forename: Uli J
authors.initials: UJ
authors.lastname: Fruth
mesh_terms: D002986:Clinical Trials as Topic / Q000379:methods / Q000592:standards* / Q000639:trends*; D006287:Health Planning Guidelines; D006801:Humans; D016896:Treatment Outcome; D014376:Tuberculosis / Q000276:immunology / Q000517:prevention & control; D032581:Tuberculosis Vaccines / Q000276:immunology* / Q000627:therapeutic use; D014944:World Health Organization
chemical_list: D032581:Tuberculosis Vaccines